Xiaohong Pu

741 total citations
41 papers, 486 citations indexed

About

Xiaohong Pu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Xiaohong Pu has authored 41 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Surgery and 15 papers in Oncology. Recurrent topics in Xiaohong Pu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Xiaohong Pu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Xiaohong Pu collaborates with scholars based in China, United States and Malaysia. Xiaohong Pu's co-authors include Shen Yue, Steven Y. Cheng, Lu Xie, Yan Chen, Tian Jin, Beicheng Sun, Yao Fu, Xiangshan Fan, Jiong Shi and Evangeline Mose and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Cell and Scientific Reports.

In The Last Decade

Xiaohong Pu

38 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Pu China 11 278 126 96 82 77 41 486
Eleanor Hilliard United States 12 356 1.3× 106 0.8× 88 0.9× 64 0.8× 81 1.1× 18 563
Xiaohuan Gao United States 9 303 1.1× 166 1.3× 85 0.9× 93 1.1× 76 1.0× 15 538
Patrick Eulitt United States 8 223 0.8× 154 1.2× 83 0.9× 38 0.5× 73 0.9× 18 474
Laura Wilson United Kingdom 13 345 1.2× 150 1.2× 78 0.8× 105 1.3× 184 2.4× 23 563
John M. Krill-Burger United States 11 504 1.8× 88 0.7× 62 0.6× 118 1.4× 61 0.8× 14 679
I‐Ying Kuo Taiwan 14 357 1.3× 109 0.9× 66 0.7× 123 1.5× 70 0.9× 24 520
Roxane M. Pommier France 11 224 0.8× 149 1.2× 87 0.9× 107 1.3× 47 0.6× 19 443
Rajat Banerjee United States 14 393 1.4× 192 1.5× 56 0.6× 153 1.9× 86 1.1× 19 630
Pavel Mazánek Czechia 12 291 1.0× 105 0.8× 40 0.4× 104 1.3× 52 0.7× 26 524
Feda H. Hamdan United States 16 326 1.2× 146 1.2× 56 0.6× 103 1.3× 28 0.4× 25 507

Countries citing papers authored by Xiaohong Pu

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Pu more than expected).

Fields of papers citing papers by Xiaohong Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Pu. The network helps show where Xiaohong Pu may publish in the future.

Co-authorship network of co-authors of Xiaohong Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Pu. A scholar is included among the top collaborators of Xiaohong Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Pu. Xiaohong Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yan, Xiaofeng Shen, Shuo Zhang, et al.. (2025). FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma. Advanced Science. 13(3). e10782–e10782.
2.
Cui, Xiaohan, Zhu Xu, Zechuan Zhang, et al.. (2024). Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. Journal of Hepatology. 81(5). 847–861. 28 indexed citations
3.
Pu, Xiaohong, Feng Xu, Ziyu Wang, et al.. (2024). HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment. Journal of Cancer Research and Clinical Oncology. 150(8). 403–403. 1 indexed citations
4.
Zhang, Xiaomei, Lin Li, Fuping Gao, et al.. (2024). Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements. Diagnostic Pathology. 19(1). 1–1. 3 indexed citations
5.
Cai, Jing, Yue Wang, Xinfa Wang, et al.. (2023). AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation. Cell & Bioscience. 13(1). 15–15. 11 indexed citations
6.
Pu, Xiaohong, et al.. (2023). NTRK gene alterations were enriched in hepatoid or enteroblastic differentiation type of gastric cancer. Journal of Clinical Pathology. 77(9). 608–613. 6 indexed citations
7.
Yang, H. J., Biao Zhang, Wenyan Guan, et al.. (2023). Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes. Cancer Medicine. 12(9). 10575–10586. 5 indexed citations
8.
Guo, Wei, et al.. (2023). Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma. Frontiers in Oncology. 13. 1116648–1116648. 4 indexed citations
9.
Sun, Qi, Qi Li, Fuping Gao, et al.. (2022). HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria. Journal of Cancer Research and Clinical Oncology. 149(2). 579–592. 4 indexed citations
10.
Pu, Xiaohong, Qing Ye, Jing Cai, et al.. (2021). Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas. Cell Death and Disease. 12(3). 256–256. 20 indexed citations
11.
12.
Pu, Xiaohong, Lu He, Yao Fu, et al.. (2021). Malignant Gastrointestinal Neuroectodermal Tumor in the Right Heart: A Report of an Extremely Rare Case Presenting With a Cardiac Mass. Frontiers in Cardiovascular Medicine. 8. 702215–702215. 4 indexed citations
13.
Fu, Yao, Zheng Li, Fuping Gao, et al.. (2021). MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence In Situ Hybridization Positive Colorectal Carcinomas. Frontiers in Oncology. 11. 669197–669197. 8 indexed citations
14.
Li, Qi, Xiaomin Feng, Fengnan Niu, et al.. (2021). Inhibition of p22phox Suppresses Epithelial Ovarian Cancer Cell Proliferation and Tumorigenesis. Journal of Cancer. 12(14). 4277–4287. 4 indexed citations
15.
Cai, Jing, et al.. (2020). Protein phosphatase 4 promotes Hedgehog signaling through dephosphorylation of Suppressor of fused. Cell Death and Disease. 11(8). 686–686. 9 indexed citations
16.
Pu, Xiaohong, Hongwei Zheng, Xin Yang, et al.. (2020). An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy. BMC Gastroenterology. 20(1). 367–367. 2 indexed citations
17.
Pu, Xiaohong, Feng Li, Jinyu Zheng, et al.. (2020). Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population. Pathology - Research and Practice. 216(9). 153116–153116. 7 indexed citations
18.
Pu, Xiaohong, Shen Yue, Hongyan Wu, et al.. (2020). C-MET in intrahepatic cholangiocarcinoma: High-Frequency amplification predicts protein expression and a unique molecular subtype. Pathology - Research and Practice. 216(4). 152857–152857. 7 indexed citations
19.
Pu, Xiaohong, Yao Fu, Zhiwen Fan, et al.. (2018). Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer. Medicine. 97(15). e0353–e0353. 8 indexed citations
20.
Pu, Xiaohong, Jiong Shi, Zhiwen Li, An‐Ning Feng, & Qing Ye. (2014). Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer. Pathology - Research and Practice. 211(6). 421–425. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleanor Hilliard Breakdown of academic impact, for papers by Xiaohuan Gao Breakdown of academic impact, for papers by Patrick Eulitt Breakdown of academic impact, for papers by Laura Wilson Breakdown of academic impact, for papers by John M. Krill-Burger Breakdown of academic impact, for papers by I‐Ying Kuo Breakdown of academic impact, for papers by Roxane M. Pommier Breakdown of academic impact, for papers by Rajat Banerjee Breakdown of academic impact, for papers by Pavel Mazánek Breakdown of academic impact, for papers by Feda H. Hamdan
Rankless by CCL
2026